RE: Whether Resmed is really a good buy following this drop
While a reduction of ~13% from the ATH of $29 may seem like a good entry point upon first inspection, I have taken the weekend to take a further look into the price at the moment.
Currently a price of $25.06 represents both a trailing and forward PE of 39.8 which is still significantly higher than its historical PE averages of 32.8 (2019), 26 (2018), 25.9 (2017), 22.7 (2016) according to nabtrade and makes it still look slightly overvalued right now.
I would love to hear what you all think of this rudimentary analysis. I am currently a holder with a long term view and may pick some up today however it does not seem to be that banger of a price.
RE: Whether Resmed is really a good buy following this dropWhile...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$29.10 |
Change
0.320(1.11%) |
Mkt cap ! $18.47B | |||
| Open | High | Low | Value | Volume |
| $29.11 | $29.39 | $29.06 | $79.72M | 2.743M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1068 | $29.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $29.11 | 5546 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| RMD (ASX) Chart |